DOJ Closing Abbott Labs Case Spurs Wider Corporate Crime Retreat
The U.S. Department of Justice has reportedly retreated from aggressive corporate prosecutions following the closure of a criminal case against Abbott Laboratories. Internal sources suggest that leadership is now imposing higher evidentiary standards, leading to stalled investigations in the food and drug sectors.
Why it matters
This shift signals a potential change in federal regulatory enforcement strategy, potentially reducing corporate accountability for health and safety violations.
Justice Department leaders’ shutdown of a long-running criminal case against Abbott Laboratories over contaminated baby formula has fueled a broader pullback on corporate prosecutions protecting consumer health, said people familiar with the situation.
The report relies on anonymous sources to describe internal DOJ shifts, maintaining a neutral reporting style on a sensitive legal matter.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in